Immediate Implant Placement Using the Socket Shield Technique in Maxillary Esthetic Zone

Launched by HAMS HAMED ABDELRAHMAN · Jul 23, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to place dental implants immediately after tooth removal in the upper front part of the mouth, an area that is important for how your smile looks. The technique, called the socket shield technique, aims to keep part of the tooth root in place to help protect the surrounding bone and gum tissue. This could lead to better implant stability, less bone loss, and a more natural appearance after the implant is placed.

People who might be eligible for this study are adults with a damaged upper front tooth that cannot be saved and needs to be removed, but who have good oral hygiene and a healthy surrounding bone structure. The study is not open yet for participants. If you join, you can expect careful monitoring of your implant’s stability, bone health through X-rays, and how your smile looks over time. Certain conditions, like heavy smoking, active infections, or health problems that affect healing, would make someone ineligible. This study hopes to show whether this new technique can improve outcomes for people needing implants in this visible part of the mouth.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with a non-restorable maxillary tooth in the aesthetic zone indicated for extraction and subsequent immediate implant placement.
• • Patients with extraction socket Type I.
• • A good standard of oral hygiene.
• Exclusion Criteria:
• • Patients with extraction socket Type II or III, with defect in the buccal plate.
• • Absence of at least 2 mm bone apical to the extraction socket, necessary to obtain adequate primary stability for the implant assessed by pre-operative radiographic evaluation.
• • The presence of any local factor that may interfere with extraction as tooth ankylosis.
• • Patients with deciduous teeth.
• • Patients with bruxism
• • Heavy smokers.
• • Systemic conditions that are considered as a contraindication for placement of implant or those that may interfere with wound healing and immunocompromised conditions and uncontrolled autoimmune diseases.
• • History of oral or intravenous bisphosphonate therapy or any treatments with other medications that may interfere with bone metabolism within the past 12 months.
• • Patients receiving radiotherapy or chemotheraphy.
• • Patient with active infection or chronic infection with severe bone loss.